NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Jaguar Gene Therapy

Jaguar Gene Therapy

Private
Lake Forest, IllinoisHealthcare & Life Scienceshttps://jaguargenetherapy.com/

Last Round

Strategic

Mar 29, 2022

Total Funding Raised

$179M

Company Overview

Jaguar Gene Therapy is a biotechnology company that develops gene therapy treatments to address severe genetic diseases by restoring gene function through the introduction of healthy gene copies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyAAVadeno-associated virusbiotechclinical-stage biotechgenetic diseaseclinical trialsbiologicscontract manufacturingCMCchemistry manufacturing and controlsPPQ manufacturingprocess performance qualificationrare diseaseorphan drug

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Jaguar Gene Therapy Comparables

Compare Jaguar Gene Therapy with similar companies based on industry and business-model similarity.

Jaguar Gene Therapy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Capsida Biotherapeutics
87%
Latus Bio
81%
Roche Holding
77%

Jaguar Gene Therapy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMar 29, 2022
Series BApr 13, 2021
Series AFeb 25, 2021

Key People

Founding team and executive leadership

Joseph Nolan

President And Chief Executive Officer

Executive Team

Jaguar Gene Therapy Investors

Notable investors and investment history

Jaguar Gene Therapy investors
InvestorRounds
Deerfield ManagementSeries B, Series A
ARCH Venture PartnersSeries B
ARCH Venture PartnersSeries B
Samsung Venture InvestmentStrategic
Goldman Sachs Group, Inc.Series B
JDRFStrategic
Nolan CapitalSeries B

Jaguar Gene Therapy Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Jaguar Gene Therapy Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Jaguar Gene Therapy's valuation, stock price, and market status.

Firmographic Details

HeadquartersLake Forest, Illinois
Employee Range48
Year Founded2019
Last FundingMar 29, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.